pET-Cas9-NLS-6xHis Citations (7)
Originally described in: Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo.Zuris JA, Thompson DB, Shu Y, Guilinger JP, Bessen JL, Hu JH, Maeder ML, Joung JK, Chen ZY, Liu DR Nat Biotechnol. 2015 Jan;33(1):73-80. doi: 10.1038/nbt.3081. Epub 2014 Oct 30. PubMed Journal
Articles Citing pET-Cas9-NLS-6xHis
| Articles |
|---|
| Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles. Wang M, Zuris JA, Meng F, Rees H, Sun S, Deng P, Han Y, Gao X, Pouli D, Wu Q, Georgakoudi I, Liu DR, Xu Q. Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):2868-73. doi: 10.1073/pnas.1520244113. Epub 2016 Feb 29. PubMed |
| Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity. O'Reilly D, Kartje ZJ, Ageely EA, Malek-Adamian E, Habibian M, Schofield A, Barkau CL, Rohilla KJ, DeRossett LB, Weigle AT, Damha MJ, Gagnon KT. Nucleic Acids Res. 2019 Jan 25;47(2):546-558. doi: 10.1093/nar/gky1214. PubMed |
| Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9. Barkau CL, O'Reilly D, Rohilla KJ, Damha MJ, Gagnon KT. Nucleic Acid Ther. 2019 Jun;29(3):136-147. doi: 10.1089/nat.2018.0758. Epub 2019 Apr 16. PubMed |
| A Targeted and Tuneable DNA Damage Tool Using CRISPR/Cas9. Emmanouilidis I, Fili N, Cook AW, Hari-Gupta Y, Dos Santos A, Wang L, Martin-Fernandez ML, Ellis PJI, Toseland CP. Biomolecules. 2021 Feb 15;11(2):288. doi: 10.3390/biom11020288. PubMed |
| CRISPA: A Non-viral, Transient Cas9 Delivery System Based on Reengineered Anthrax Toxin. Hirschenberger M, Stadler N, Fellermann M, Sparrer KMJ, Kirchhoff F, Barth H, Papatheodorou P. Front Pharmacol. 2021 Oct 18;12:770283. doi: 10.3389/fphar.2021.770283. eCollection 2021. PubMed |
A cleavage rule for selection of increased-fidelity SpCas9 variants with high efficiency and no detectable off-targets.
Kulcsar PI, Talas A, Ligeti Z, Toth E, Rakvacs Z, Bartos Z, Krausz SL, Welker A, Vegi VL, Huszar K, Welker E.
Nat Commun. 2023 Sep 16;14(1):5746. doi: 10.1038/s41467-023-41393-5.
PubMed
Associated Plasmids |
| Causal ALS genes impact the MHC class II antigen presentation pathway. Chi B, Ozturk MM, Paraggio CL, Leonard CE, Sanita ME, Dastpak M, O'Connell JD, Coady JA, Zhang J, Gygi SP, Lopez-Gonzalez R, Yin S, Reed R. Proc Natl Acad Sci U S A. 2023 Sep 26;120(39):e2305756120. doi: 10.1073/pnas.2305756120. Epub 2023 Sep 18. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.